Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Exactech, Inc.

United States·US-MF-000017730

Last updated September 17, 2026

What Exactech, Inc. makes

Exactech, Inc. manufactures orthopaedic implants and surgical instruments, including tibial inserts, knee and ankle prostheses (both trial and fixed-bearing), acetabular shells, and non-bioabsorbable orthopaedic bone screws. Their reusable trial components for knee and tibia prostheses, as well as instrument trays, support preoperative planning and intraoperative procedures. Fixed-bearing total ankle prostheses and acetabular shells are designed for primary and revision joint replacements.

The company’s devices are classified under FDA’s Class I and Class II categories and are listed in the FDA’s Unique Device Identifier (UDI) database. Their products are regulated under the U.S. Food and Drug Administration’s medical device rules, with compliance required for market distribution in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Exactech, Inc. manufacture?

Exactech, Inc. specializes in orthopaedic implants and surgical instruments. Their product lineup includes tibial inserts, knee and ankle prostheses (both trial and fixed-bearing types), acetabular shells, and non-bioabsorbable orthopaedic bone screws. They also produce reusable trial components for knee and tibia prostheses, as well as instrument trays, which aid in preoperative planning and intraoperative procedures. These devices are designed for joint replacement surgeries, including primary and revision cases.

Where is Exactech, Inc. based?

Exactech, Inc. is headquartered in the United States. While the exact location isn’t specified, the company operates within the U.S. regulatory framework, which governs its medical device offerings.

Which regulatory registries list Exactech, Inc.’s devices?

Exactech, Inc.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and compliance tracking for medical devices marketed in the United States, aligning with FDA requirements for device identification and reporting.

How are Exactech, Inc.’s devices classified under FDA regulations?

Exactech, Inc.’s devices fall under FDA’s Class I and Class II categories. Class I devices generally pose minimal risk and are subject to general controls, while Class II devices require additional performance standards or special controls due to moderate risk. The classification depends on factors like the device’s intended use, potential risks, and the body part involved, ensuring appropriate regulatory oversight.

What is the purpose of Exactech’s reusable trial components and instrument trays?

Exactech’s reusable trial components, such as knee and tibia prosthesis trials, are designed for intraoperative use to assess fit, alignment, and function before final implantation. These components help surgeons plan and refine the procedure, reducing the risk of complications. Instrument trays, also reusable, contain the necessary tools for surgical procedures, ensuring efficiency and sterility during orthopaedic surgeries.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
United States
Address
2320, NW 66th Court, Gainesville, United States
LinkedIn
—
Facebook
—
Phone
(352) 377-1140
PRRC Contact
Christine Thomas
EUDAMED SRN
US-MF-000017730
FDA FEI Number
1038671
DUNS Number
157565946

Catalogue (10455)

Page 45 of 210
DeviceModel / ReferenceRegistriesClassStatus
Exactech 148-36-03
FDA UDI
Class IIUnknown
Truliant SPI-011531
FDA UDI
Class IActive
Vantage 03-LNR-PG-0003
FDA UDI
Class IIActive
Equinoxe® 320-55-08
FDA UDI
Class IIActive
AcuMatch 148-28-27
FDA UDI
Class IIActive
Truliant SPI-040344
FDA UDI
Class IIActive
Optetrak Logic 02-010-03-0310
FDA UDI
Class IIActive
Optetrak 204-46-04
FDA UDI
Class IIActive
Acumatch M-Series 150-01-03
FDA UDI
Class IIUnknown
Optetrak Logic 02-013-42-2008
FDA UDI
Class IUnknown
Epic 2001-4556
FDA UDI
Class IIActive
Alteon 180-65-35
FDA UDI
Class IIActive
Truliant 02-022-51-2519
FDA UDI
Class IIActive
Equinoxe 314-06-24
FDA UDI
Class IIActive
Alteon 01-031-46-0432
FDA UDI
Class IActive
Vantage 351-03-12
FDA UDI
Class IActive
Alteon 01-010-19-4195
FDA UDI
Class IIActive
Optetrak Logic 02-012-60-2480
FDA UDI
Class IIActive
Vantage 351-91-10
FDA UDI
Class IActive
Alteon 190-11-08
FDA UDI
Class IIActive
Optetrak Logic 02-012-50-2004
FDA UDI
Class IIUnknown
Truliant 02-022-35-3514
FDA UDI
Class IIActive
Exactech 142-28-10
FDA UDI
Class IIActive
Acumatch C Series 116-30-06
FDA UDI
Class IIUnknown
Alteon 188-00-07
FDA UDI
Class IIActive
Optetrak Logic 02-013-65-1111
FDA UDI
Class IActive
AcuMatch M-Series 150-25-02
FDA UDI
Class IIUnknown
Epic 2000-5530
FDA UDI
Class IIActive
Vantage 351-01-01
FDA UDI
Class IActive
Truliant CC 02-019-30-0000
FDA UDI
Class IIActive
Truliant CC 02-013-50-2514
FDA UDI
Class IIActive
Equinoxe 320-15-06
FDA UDI
Class IIActive
Novation Ceramic AHS 141-00-12
FDA UDI
Class IUnknown
Equinoxe 314-04-24
FDA UDI
Class IIActive
Truliant SPI-046099-35
FDA UDI
Class IActive
Vantage®, Activit-E 351-24-34
FDA UDI
Class IActive
Truliant CC 02-012-65-5015
FDA UDI
Class IIActive
Truliant® 02-022-57-1000
FDA UDI
Class IIActive
Optetrak Logic 02-012-61-6166
FDA UDI
Class IIActive
Vantage 03-CNB-AR-0000
FDA UDI
Class IIActive
Equinoxe 321-07-38
FDA UDI
Class IIActive
Acumatch A Series 132-32-30
FDA UDI
Class IIUnknown
AcuMatch 131-02-08
FDA UDI
Class IIActive
Acumatch A Series 124-01-62
FDA UDI
Class IIActive
Optetrak Logic 02-013-42-3008
FDA UDI
Class IUnknown
Truliant 02-029-25-3310
FDA UDI
Class IActive
Novation 180-13-52
FDA UDI
Class IIActive
Alteon 191-02-02
FDA UDI
Class IIActive
Equinoxe 314-02-23
FDA UDI
Class IIActive
Optetrak 204-26-11
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (100)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Exactech, Inc. has 221 recall records spanning from June 17, 2003, to February 3, 2026, with statuses including completed, open, classified, and terminated. The reasons cited involve labeling inaccuracies—such as incorrect size information, transposed device labels, and mismatched inner packaging—along with design and manufacturing issues, including missing components (e.g., cross-pins), improper markings, misalignment of fixation holes, and non-conforming threads. Some recalls address updated instructions for use to clarify surgical techniques, while others involve uncompleted design updates or missing specified coatings on implants.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Feb 3, 2026Z-1510-2026—open, classified

Impactor handle may be missing cross-pin

Feb 3, 2026Z-1509-2026—open, classified

Impactor handle may be missing cross-pin

Sep 5, 2025Z-0536-2026—open, classified

Due to products that have not completed design updates and performance testing being released/distributed. Products may not conform to design and performance criteria.

Sep 5, 2025Z-0537-2026—open, classified

Due to products that have not completed design updates and performance testing being released/distributed. Products may not conform to design and performance criteria.

Sep 5, 2025Z-0535-2026—open, classified

Due to products that have not completed design updates and performance testing being released/distributed. Products may not conform to design and performance criteria.

Aug 15, 2025Z-2561-2025—open, classified

Reverse Shoulder humeral liners have an articular surface position outside of the dimensional specification within the labeling.

Aug 15, 2025Z-2562-2025—open, classified

Reverse Shoulder humeral liners have an articular surface position outside of the dimensional specification within the labeling.

Dec 31, 2024Z-1166-2025—open, classified

Due to the lack of the Ethylene Vinyl Alcohol (EVOH) barrier layer.

Dec 31, 2024Z-1167-2025—open, classified

Due to the lack of the Ethylene Vinyl Alcohol (EVOH) barrier layer.

Dec 31, 2024Z-1165-2025—open, classified

Due to the lack of the Ethylene Vinyl Alcohol (EVOH) barrier layer.

Apr 26, 2024Z-2236-2024—open, classified

The AcuMatch L-Series 22mm Inner Diameter Bipolar Hip Liner lots were packaged without the specified ethylene vinyl alcohol (EVOH) layer. Between 2004 and August 2021, our packaging process utilized two different types of packaging materials: 1) Low Density Polyethylene (LDPE), Nylon, and EVOH, or 2) LDPE and Nylon without EVOH.

Apr 18, 2024Z-2156-2024—open, classified

Exactech is recalling all affected UHMWPE (ultra-high molecular weight polyethylene) knee patella components packaged in out of specification vacuum bags.

Apr 18, 2024Z-2158-2024—open, classified

Exactech is recalling all affected UHMWPE (ultra-high molecular weight polyethylene) knee patella components packaged in out of specification vacuum bags.

Apr 18, 2024Z-2155-2024—open, classified

Exactech is recalling all affected UHMWPE (ultra-high molecular weight polyethylene) knee patella components packaged in out of specification vacuum bags.

Apr 18, 2024Z-2157-2024—open, classified

Exactech is recalling all affected UHMWPE (ultra-high molecular weight polyethylene) knee patella components packaged in out of specification vacuum bags.

Mar 6, 2024Z-1420-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1423-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1414-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1422-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1406-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1409-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1415-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1405-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1416-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1403-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1407-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1411-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1410-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1425-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1412-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1417-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1424-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1404-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1402-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1408-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1421-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1413-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1418-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Mar 6, 2024Z-1419-2024—open, classified

The packaging of these affected UHMWPE humeral liners and glenoids are nonconforming as they do not meet the established packaging specification. They were packaged in vacuum bags that did not contain an additional oxygen barrier layer consisting of Ethylene Vinyl Alcohol (EVOH).

Nov 21, 2023Z-0582-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0587-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0588-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0586-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0584-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0581-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0580-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0583-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0585-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0579-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0578-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Nov 21, 2023Z-0577-2024—open, classified

Exactech has received 3 complaints for 4 devices related to a loss of vacuum in the inner-most vacuum bag.

Jun 5, 2023Z-2051-2023—open, classified

The ball and spring housed within the locking mechanism of the handle can dislodge during disassembly or during impaction.

Jun 5, 2023Z-2050-2023—open, classified

The ball and spring housed within the locking mechanism of the handle can dislodge during disassembly or during impaction.

Aug 11, 2022Z-1726-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1733-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1725-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1729-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1730-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1734-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1728-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1727-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1732-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 11, 2022Z-1731-2022—open, classified

Specific GXL acetabular polyethylene liners, packaged in non-conforming bags, may adversely impact the device and contribute to accelerated wear.

Aug 30, 2021Z-0027-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0022-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0021-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0026-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0020-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0019-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0024-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0025-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Aug 30, 2021Z-0023-2022—open, classified

Inserts were packaged in vacuum bags that lacked an additional oxygen barrier layer.

Jun 29, 2021Z-2131-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2127-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2113-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2126-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2118-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2112-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2130-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2120-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2119-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2133-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2123-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2121-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2114-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2132-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2124-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2129-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2122-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2115-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2116-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2250-2021—completed

Biolox Delta Femoral Head was packaged and labeled as 170-36-00 (36mm +0), but the device was marked as 170-36-03 (36mm +3.5).

Jun 29, 2021Z-2128-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2117-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2125-2021—open, classified

Risk of edge-loading and premature prosthesis wear is possible in a specific subset of patients with certain implant configurations and surgical implant positioning.

Jun 29, 2021Z-2251-2021—completed

Biolox Delta Femoral Head was packaged and labeled as 170-36-00 (36mm +0), but the device was marked as 170-36-03 (36mm +3.5).

May 11, 2021Z-1977-2021—completed

The HAT trial contains a retaining ring that has shown the potential to disengage during use.

Nov 9, 2020Z-0884-2021—open, classified

Potential for incorrect Instructions For Use (IFU) included with an Equinoxe Humeral Stem, Primary, Press Fit, 11mm package.

Oct 6, 2020Z-0459-2021—terminated

The product may be mislabeled.

Oct 6, 2020Z-0460-2021—terminated

The product may be mislabeled.